These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 35147099)
1. Moyamoya disease with Sjogren disease and autoimmune thyroiditis presenting with left intracranial hemorrhage after messenger RNA-1273 vaccination: A case report. Lin YH; Huang H; Hwang WZ Medicine (Baltimore); 2022 Feb; 101(6):e28756. PubMed ID: 35147099 [TBL] [Abstract][Full Text] [Related]
2. [Concomitant intracerebral hemorrhage and cerebral infarction in moyamoya disease: a case report]. Tomii M; Nishino A; Hirano Y; Matsushima T; Mizuno J No Shinkei Geka; 2011 Sep; 39(9):871-5. PubMed ID: 21873742 [TBL] [Abstract][Full Text] [Related]
3. Neuro-endoscopic management of hemorrhagic moyamoya disease in the acute stage: single institute experience. Mino M; Fujimura M; Endo H; Endo T; Sato K; Tominaga T Neurol Res; 2019 Dec; 41(12):1097-1103. PubMed ID: 31608819 [No Abstract] [Full Text] [Related]
4. Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental? Syed K; Chaudhary H; Donato A Am J Case Rep; 2021 Sep; 22():e933397. PubMed ID: 34478433 [TBL] [Abstract][Full Text] [Related]
5. A Case of Neurofibromatosis Type 1 Complicated with Repeated Intracerebral Hemorrhage due to Quasi-Moyamoya Disease. Hayashi K; Morofuji Y; Horie N; Izumo T J Stroke Cerebrovasc Dis; 2015 May; 24(5):e109-13. PubMed ID: 25804563 [TBL] [Abstract][Full Text] [Related]
6. A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Mechanical Thrombectomy. Gurjar H; Dhallu M; Lvovsky D; Sadullah S; Chilimuri S Am J Case Rep; 2022 Feb; 23():e935355. PubMed ID: 35181646 [TBL] [Abstract][Full Text] [Related]
7. Intracranial carotid artery stent placement causes delayed severe intracranial hemorrhage in a patient with moyamoya disease. Eicker S; Etminan N; Turowski B; Steiger HJ; Hänggi D J Neurointerv Surg; 2011 Jun; 3(2):160-2. PubMed ID: 21990810 [TBL] [Abstract][Full Text] [Related]
8. A Possible Case of Hypertensive Crisis With Intracranial Haemorrhage After an mRNA Anti-COVID-19 Vaccine. Athyros VG; Doumas M Angiology; 2022 Jan; 73(1):87. PubMed ID: 34018416 [No Abstract] [Full Text] [Related]
9. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review. Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB Front Public Health; 2021; 9():778964. PubMed ID: 34888290 [No Abstract] [Full Text] [Related]
10. Treatment of aneurysms in patients with moyamoya disease: a 10-year single-center experience. Ni W; Jiang H; Xu B; Lei Y; Yang H; Su J; Gu Y; Mao Y J Neurosurg; 2018 Jun; 128(6):1813-1822. PubMed ID: 28841118 [TBL] [Abstract][Full Text] [Related]
11. Intracranial Hemorrhage After Superficial Temporal Artery-Middle Cerebral Artery Direct Anastomosis for Adults with Moyamoya Disease. Park W; Park ES; Lee S; Park JC; Chung J; Lee JM; Ahn JS World Neurosurg; 2018 Nov; 119():e774-e782. PubMed ID: 30096496 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Presenting With Thalamic Hemorrhage Unmasking Moyamoya Angiopathy. Ghosh R; Dubey S; Kanti Ray B; Chatterjee S; Benito-León J Can J Neurol Sci; 2020 Nov; 47(6):849-851. PubMed ID: 32493536 [No Abstract] [Full Text] [Related]
13. Moyamoya disease presenting with subarachnoid hemorrhage: Clinical features and neuroimaging of a case series. Wan M; Han C; Xian P; Yang WZ; Li DS; Duan L Br J Neurosurg; 2015; 29(6):804-10. PubMed ID: 26313681 [TBL] [Abstract][Full Text] [Related]
14. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial. Oosting SF; van der Veldt AAM; GeurtsvanKessel CH; Fehrmann RSN; van Binnendijk RS; Dingemans AC; Smit EF; Hiltermann TJN; den Hartog G; Jalving M; Westphal TT; Bhattacharya A; van der Heiden M; Rimmelzwaan GF; Kvistborg P; Blank CU; Koopmans MPG; Huckriede ALW; van Els CACM; Rots NY; van Baarle D; Haanen JBAG; de Vries EGE Lancet Oncol; 2021 Dec; 22(12):1681-1691. PubMed ID: 34767759 [TBL] [Abstract][Full Text] [Related]
15. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A Front Immunol; 2021; 12():780594. PubMed ID: 34925359 [TBL] [Abstract][Full Text] [Related]
16. Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine. Tao J; Rosenfeld D; Hsu J; Bhatia A Cutis; 2022 Mar; 109(3):148-149. PubMed ID: 35659140 [TBL] [Abstract][Full Text] [Related]
17. Delayed cerebral ischemia associated with reversible cerebral vasoconstriction in a patient with Moyamoya disease with intraventricular hemorrhage: Case report. Matsuoka G; Kubota Y; Okada Y Neuroradiol J; 2015 Jun; 28(3):322-4. PubMed ID: 26246103 [TBL] [Abstract][Full Text] [Related]
18. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report. Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163 [TBL] [Abstract][Full Text] [Related]
20. Hemorrhagic moyamoya disease in children: clinical features and surgical outcome. Ahn JH; Wang KC; Phi JH; Lee JY; Cho BK; Kim IO; Kim SK Childs Nerv Syst; 2012 Feb; 28(2):237-45. PubMed ID: 21805358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]